Maryland SB196 establishes a medication review committee to determine the administration of psychotropic medication to incarcerated individuals who.

Maryland SB196 creates a medication review committee within the Department of Public Safety and Correctional Services. This committee convenes to decide whether to approve the administration of psychotropic medication to incarcerated individuals who refuse it. The bill outlines specific conditions under which such medication can be administered, including emergency situations and non-emergency cases where the individual poses a danger to themselves or others. The committee must base its decision on clinical assessments and must document its considerations and decisions.

Maryland SB196 establishes a medication review committee to determine the administration of psychotropic medication to incarcerated individuals who.

Maryland SB196 creates a medication review committee within the Department of Public Safety and Correctional Services. This committee convenes to decide whether to approve the administration of psychotropic medication to incarcerated individuals who refuse it. The bill outlines specific conditions under which such medication can be administered, including emergency situations and non-emergency cases where the individual poses a danger to themselves or others. The committee must base its decision on clinical assessments and must document its considerations and decisions.